Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Monthly Archives: October 2020

MissionIRNewsBreaks – SRAX Inc. (NASDAQ: SRAX) Sells Remaining MD Ownership Stake

SRAX (NASDAQ: SRAX), an innovative fintech solutions provider that unlocks data and insights for publicly traded companies through its SaaS platform, Sequire, today announced that it has sold its remaining interest in the SRAX MD asset. “Our SEQUIRE platform is … Continue reading

Posted in MissionIRNewsBreaks, SRAX, Inc. SRAX | Leave a comment

MissionIRNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Announces Launch of New Branding for Upcoming Combination Clinical Trials

Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company developing potentially life-changing technologies for cancer and diabetes patients, today announced the launch of new branding for its upcoming oncology clinical trials. The trials combine Genprex’s lead drug candidate, REQORSA(TM) (quaratusugene ozeplasmid), … Continue reading

Posted in Genprex Inc. GNPX, MissionIRNewsBreaks | Leave a comment

MissionIRNewsBreaks – Wrap Technologies Inc. (NASDAQ: WRTC) Announces Q3 2020 Results, Appointment of Interim CEO and Chief Govt Affairs Officer

Wrap Technologies (NASDAQ: WRTC), an innovator of modern policing solutions, on Thursday announced results for its third quarter ended September 30, 2020. Among the Q3 highlights, the company reported a 275% growth in net sells, a gross margin of 32% … Continue reading

Posted in MissionIRNewsBreaks, Wrap Technologies Inc. WRTC | Leave a comment

MissionIRNewsBreaks – VistaGen Therapeutics (NASDAQ: VTGN) Featured in BioWorld Article

VistaGen Therapeutics (NASDAQ: VTGN), a biopharmaceutical company developing new generation medicines for anxiety, depression and other central nervous system (“CNS”) disorders, was featured in a recent BioWorld article titled, “CBC-funded Affamed merges with Everinsight, extends portfolio with Kissei PD candidate.” … Continue reading

Posted in MissionIRNewsBreaks, VistaGen Therapeutics Inc. VTGN | Leave a comment

MissionIRNewsBreaks – Sustainable Green Team Ltd. (SGTM) Announces Audit Completion, Preparation for Uplisting, Receipt of New Order from 7-Eleven Stores

Sustainable Green Team (OTC: SGTM), a leading provider of environmentally beneficial solutions for tree and storm waste disposal, announced completion of its two-year 2018 and 2019 audit to commence the form-10 process to become fully reporting and for future uplisting. … Continue reading

Posted in MissionIRNewsBreaks, Sustainable Green Team Ltd. SGTM | Leave a comment

MissionIRNewsBreaks – The Alkaline Water Company Inc. (NASDAQ: WTER) (CSE: WTER) Announces Addition of BettermentRS, a Leading CBD Distributor

The Alkaline Water Company Inc. (NASDAQ: WTER) (CSE: WTER), a producer of premium bottled alkaline water, flavor-infused waters and CBD-infused products, has added health and wellness, CBD-focused, direct-store delivery (DSD) distributor BettermentRS to its list of distributors. The move will enhance … Continue reading

Posted in MissionIRNewsBreaks, The Alkaline Water Company Inc. WTER | Leave a comment

MissionIRNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Announces Conditional FDA Acceptance of Proprietary Name for Lead Drug Candidate

Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company developing potentially life-changing technologies for patients with cancer and diabetes, has received conditional FDA acceptance of the proprietary name REQORSA(TM), its lead drug candidate for treatment of non-small cell lung cancer. The … Continue reading

Posted in Genprex Inc. GNPX, MissionIRNewsBreaks | Leave a comment

MissionIRNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Announces Completion of Drug for Clinical Trials

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers of the central nervous system, has through its European manufacturer, BSP Pharmaceuticals S.p.A. (“BSP”), finished manufacturing its lead drug candidate for … Continue reading

Posted in CNS Pharmaceuticals Inc. CNSP, MissionIRNewsBreaks | Leave a comment

SRAX Inc. (NASDAQ: SRAX) CEO and LD Micro President Discuss Impending Synergistic Acquisition as BIGtoken Announces New Additions to Board of Directors

SRAX CEO Christopher Miglino recently joined LD Micro president Chris Lahiji on Stock2Me podcast, discussed SRAX’s recent purchase of LD Micro’s business SRAX’s Miglino noted that acquisition of LD Micro would allow SRAX’s investor intelligence platform, Sequire, to broaden range … Continue reading

Posted in SRAX, Inc. SRAX | Leave a comment

MissionIRNewsBreaks – AzurRx BioPharma Inc. (NASDAQ: AZRX) Secures Financing to Fund Phase 2 Clinical Trials and Phase 3 Preparations

AzurRx BioPharma (NASDAQ: AZRX), a clinical-stage biopharmaceutical company, in July entered into a convertible preferred stock and warrant securities purchase agreement with certain accredited and institutional investors relating to the private placement of certain shares of convertible preferred stock and warrants … Continue reading

Posted in AzurRx BioPharma Inc. AZRX, MissionIRNewsBreaks | Leave a comment